| Cote dIvoire | | |
Incidents of all cancers (age-standardized rate, per 100,000 population) | 123.3 (2020) [136/185countries] | | | Incidents of cancer at bladder (age-standardized rate, per 100,000 population) | 1.0 (2020) [172/184countries] | | | Incidents of cancer at brain, central nervous system (age-standardized rate, per 100,000 population) | 1.2 (2020) [149/181countries] | | | Incidents of cancer at breast (age-standardized rate, per 100,000 population) | 44.7 (2020) [94/185countries] | | | Incidents of cancer at cervix uteri (age-standardized rate, per 100,000 population) | 31.2 (2020) [28/185countries] | | | Incidents of cancer at colorectum (age-standardized rate, per 100,000 population) | 3.6 (2020) [153/185countries] | | | Incidents of cancer at corpus uteri (age-standardized rate, per 100,000 population) | 4.5 (2020) [116/183countries] | | | Incidents of cancer at gallbladder (age-standardized rate, per 100,000 population) | 0.7 (2020) [77/177countries] | | | Incidents of cancer at kidney (age-standardized rate, per 100,000 population) | 1.4 (2020) [132/182countries] | | | Incidents of cancer at larynx (age-standardized rate, per 100,000 population) | 1.0 (2020) [134/184countries] | | | Incidents of cancer at leukaemia (age-standardized rate, per 100,000 population) | 1.8 (2020) [162/185countries] | | | Incidents of cancer at lip and oral cavity (age-standardized rate, per 100,000 population) | 1.3 (2020) [141/183countries] | | | Incidents of cancer at liver (age-standardized rate, per 100,000 population) | 7.9 (2020) [48/185countries] | | | Incidents of cancer at lung (age-standardized rate, per 100,000 population) | 2.6 (2020) [166/185countries] | | | Incidents of cancer at skin (age-standardized rate, per 100,000 population) | 2.0 (2020) [149/183countries] | | | Incidents of cancer at multiple myeloma (age-standardized rate, per 100,000 population) | 1.1 (2020) [105/178countries] | | | Incidents of cancer at nasopharynx (age-standardized rate, per 100,000 population) | 0.5 (2020) [79/172countries] | | | Incidents of cancer at lymphoma (age-standardized rate, per 100,000 population) | 5.3 (2020) [116/184countries] | | | Incidents of cancer at oesophagus (age-standardized rate, per 100,000 population) | 0.7 (2020) [170/183countries] | | | Incidents of cancer at oropharynx (age-standardized rate, per 100,000 population) | 0.3 (2020) [120/173countries] | | | Incidents of cancer at ovary (age-standardized rate, per 100,000 population) | 4.1 (2020) [146/185countries] | | | Incidents of cancer at pancreas (age-standardized rate, per 100,000 population) | 2.4 (2020) [125/184countries] | | | Incidents of cancer at prostate (age-standardized rate, per 100,000 population) | 48.0 (2020) [70/185countries] | | | Incidents of cancer at stomach (age-standardized rate, per 100,000 population) | 4.6 (2020) [123/184countries] | | | Incidents of cancer at testis (age-standardized rate, per 100,000 population) | 0.1 (2020) [166/174countries] | | | Incidents of cancer at thyroid (age-standardized rate, per 100,000 population) | 0.9 (2020) [162/184countries] | | |
|
| Cote dIvoire | | |
Suicide, age-standardized (per 100 000 population) | 15.66 (2019) [26/183countries] | | | Suicide - male, age-standardized (per 100 000 population) | 25.65 (2019) [26/183countries] | | | Suicide - female, age-standardized (per 100 000 population) | 5.03 (2019) [71/183countries] | | | Suicide - 15-24 years (per 100,000 population) | 4.59 (2019) [110/183countries] | | | Suicide - 15-24 years, male (per 100,000 population) | 7.35 (2019) [100/183countries] | | | Suicide - 15-24 years, female (per 100,000 population) | 1.84 (2019) [126/183countries] | | | Suicide - 25-34 years (per 100,000 population) | 7.96 (2019) [84/183countries] | | | Suicide - 25-34 years, male (per 100,000 population) | 13.34 (2019) [73/183countries] | | | Suicide - 25-34 years, female (per 100,000 population) | 2.63 (2019) [113/183countries] | | | Suicide - 35-44 years (per 100,000 population) | 12.40 (2019) [58/183countries] | | | Suicide - 35-44 years, male (per 100,000 population) | 21.33 (2019) [49/183countries] | | | Suicide - 35-44 years, female (per 100,000 population) | 3.29 (2019) [101/183countries] | | | Suicide - 45-54 years (per 100,000 population) | 23.05 (2019) [32/183countries] | | | Suicide - 45-54 years, male (per 100,000 population) | 38.66 (2019) [28/183countries] | | | Suicide - 45-54 years, female (per 100,000 population) | 5.97 (2019) [84/183countries] | | | Suicide - 55-64 years (per 100,000 population) | 36.11 (2019) [14/183countries] | | | Suicide - 55-64 years, male (per 100,000 population) | 57.28 (2019) [16/183countries] | | | Suicide - 55-64 years, female (per 100,000 population) | 11.87 (2019) [47/183countries] | | | Suicide - 65-74 years (per 100,000 population) | 59.50 (2019) [5/183countries] | | | Suicide - 65-74 years, male (per 100,000 population) | 93.45 (2019) [8/183countries] | | | Suicide - 65-74 years, female (per 100,000 population) | 20.13 (2019) [29/183countries] | | | Suicide - 75-84 years (per 100,000 population) | 80.50 (2019) [4/183countries] | | | Suicide - 75-84 years, male (per 100,000 population) | 131.30 (2019) [8/183countries] | | | Suicide - 75-84 years, female (per 100,000 population) | 28.35 (2019) [28/183countries] | | | Suicide - 85 years and over (per 100,000 population) | 279.90 (2019) [1/183countries] | | |
|
|